RCKT
Rocket Pharmaceuticals Inc
2.60$
-3.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +275.6% | +20.7% | +61.8% | +29.1% | +168.8% | +369.3% | +16.6% | +13.3% | +32.1% | +17.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +50.5% | +4.9% | +124.5% | +154.8% | -55.6% | +275.3% | +10.0% | +81.5% | +17.9% | +32.0% | +12.5% | -8.1% | -17.1% | |
| – | -42.6% | +59.5% | +271.3% | +26.2% | +26.8% | +42.6% | -2.0% | +59.3% | +49.6% | +40.7% | +24.7% | +39.1% | -15.2% | |
| – | +13.8% | +15.8% | +164.7% | +105.3% | -36.2% | +165.4% | +6.9% | +77.7% | +24.0% | +34.1% | +15.7% | +5.2% | -20.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +315.0% | +10.9% | +25.5% | +15.3% | +152.4% | +46.4% | -8.7% | +57.8% | -22.0% | -67.6% | -1.8% | +0.6% | +0.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +307.4% | -100.0% | – | -64.0% | +84.9% | +226.9% | +122.6% | +16.9% | -92.6% | -580.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.